<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03292549</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2012/30</org_study_id>
    <nct_id>NCT03292549</nct_id>
  </id_info>
  <brief_title>RObotic PArtial Nephrectomy National Study</brief_title>
  <acronym>ROPAN</acronym>
  <official_title>RObotic PArtial Nephrectomy National Study (RoPaN Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to set up the larger prospective study on robotic partial
      nephrectomy, to describe the characteristics of patients operated for kidney cancer by this
      surgical procedure and also to determine the modalities of hemostasis in this procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to describe the characteristics of patients operated
      for kidney cancer by a robotic partial nephrectomy in France (recruiting centers, patient
      profile, tumor characteristics).

      Secondary Objective(s):

        1. To describe the surgical techniques and operative development.

        2. To assess the modalities of haemostasis, during robotic partial nephrectomy.

        3. To assess peri-operative morbidity in robotic partial nephrectomy and post-operative
           complications.

        4. To assess the outcome of renal function after a robotic partial nephrectomy. This study
           is a national, multicenter, prospective, cohort.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Per and post-operative transfusion rates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Medical or surgical complication rates</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Clavien's grading</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Urinary fistula rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Necessity for nephrectomy or re-exploration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative complications evaluated according to the Clavien criteria</measure>
    <time_frame>From surgery until 1 year of follow up</time_frame>
    <description>Length of hospital stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function after robotic partial nephrectomy measured by biological parameters</measure>
    <time_frame>Follow-up during 12 months</time_frame>
    <description>Creatininemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function after robotic partial nephrectomy measured by biological parameters</measure>
    <time_frame>Follow-up during 12 months</time_frame>
    <description>MDRD GFR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per-operative modalities of haemostasis procedure</measure>
    <time_frame>At Surgery</time_frame>
    <description>Haemostasis procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Per-operative modalities of haemostatic agent</measure>
    <time_frame>At Surgery</time_frame>
    <description>Haemostatic agent</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">452</enrollment>
  <condition>Kidney Cancer</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Robotic partial surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic partial surgery</intervention_name>
    <description>Robotic partial surgery</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients operated for kidney cancer by this surgical procedure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is at least 18 years old at the time of screening

          -  Subject has been diagnosed with renal tumor(s)

          -  Subject will undergo a robot assisted partial nephrectomy

          -  Subject is willing and able to comply with the requirements of the protocol

        Exclusion Criteria: None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe BERNHARD, PHU</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HCL Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Diaconesses</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU La Pitié Salpétrière/ Kremlin Bicêtre</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Saint Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Henri MONDOR</name>
      <address>
        <city>Paris</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rennes - Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse - Centre Claudius Régaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urology</keyword>
  <keyword>Robotic surgery</keyword>
  <keyword>Haemostasis</keyword>
  <keyword>Partial Nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

